

Dan Loeb’s Third Point increased its Danaher stake to 540,000 shares in the second quarter, up from 525,000, with a $102.8 million valuation.
You can purchase shares of Danaher (NYSE:DHR) through any online brokerage.
Other companies in Danaher’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT), IQVIA Holdings Inc (NYSE:IQV) and Illumina Inc (NASDAQ:ILMN).
Danaher has a consensus price target of $253.62.
The stock price for Danaher (NYSE: DHR) is $236.37 last updated November 4, 2026 at 9:44 AM EST.
There are no upcoming dividends for Danaher.
Danaher does not have any upcoming earnings scheduled.
There is no upcoming split for Danaher.
Danaher is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific...